Biotech & MedTech
-
Bristow goes with technology and selects the stock to watch in 2022
Welcome to 2022! I’m cautiously optimistic that this will be the year we get to put Covid in…
-
David Regan on Sona Nanotech’s rapid-result saliva based COVID-19 test
In a recent InvestorIntel interview, Chris Thompson spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA |…
-
Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial
As we all know alcohol addiction is one of the worst addictions in society costing billions per year.…
-
Dr. Allen Davidoff of XORTX Therapeutics’ on developing therapies for kidney diseases and uplisting to the NASDAQ
In a recent InvestorIntel interview, Chris Thompson spoke with Dr. Allen Davidoff, CEO of XORTX Therapeutics Inc. (NASDAQ:…
-
Sona Nanotech is seeking U.S. FDA approval for its rapid COVID-19 saliva test
Much to my chagrin, it appears this damn COVID virus is refusing to let us be. I guess…
-
The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease
Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage…
-
Greg Fenton on the significant medical market interest in Zentek’s ZENGuard™ nanotech coatings, plus its new carbon-based icephobic coating
In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about Zentek’s…
-
Revolutionizing the way we treat lack of blood flow diseases by using stem cell therapy
Every year modern medicine makes new breakthroughs that continue to amaze. Today’s company has a breakthrough ‘stem cell…
